The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications
Jovian J Tsang,1,2 Harold L Atkins2,3 1Department of Biochemistry, University of Ottawa, 2Cancer Therapeutics, Ottawa Hospital Research Institute, 3Blood and Marrow Transplant Program, The Ottawa Hospital, Ottawa, ON, Canada Abstract: Hematological malignancies are treated with intensive high-dose...
Main Authors: | Tsang JJ, Atkins HL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-01-01
|
Series: | Oncolytic Virotherapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-ex-vivo-purge-of-cancer-cells-using-oncolytic-viruses-recent-advan-peer-reviewed-article-OV |
Similar Items
-
Severe Hypofunction of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Oncohematological Diseases: Incidence, Risk Factors, and Outcomes
by: TA Rudakova, et al.
Published: (2019-05-01) -
A Case of Multiple Sclerosis—Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature
by: Joyutpal Das, et al.
Published: (2020-05-01) -
Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01) -
Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
by: Kharfan-Dabaja Mohamed A, et al.
Published: (2013-01-01) -
Physiological problems in patients undergoing autologous and allogeneic hematopoietic stem cell transplantation
by: Sevgisun Kapucu, et al.
Published: (2014-01-01)